These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9700507)

  • 1. Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands.
    Brossay L; Burdin N; Tangri S; Kronenberg M
    Immunol Rev; 1998 Jun; 163():139-50. PubMed ID: 9700507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting function of the TL antigen and mouse CD1 molecules.
    Cheroutre H; Holcombe HR; Tangri S; Castaño AR; Teitell M; Miller JE; Cardell S; Benoist C; Mathis D; Huse WD
    Immunol Rev; 1995 Oct; 147():31-52. PubMed ID: 8847078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-presenting function of the mouse CD1 molecule.
    Tangri S; Holcombe HR; Castaño AR; Miller JE; Teitell M; Huse WE; Peterson PA; Kronenberg M
    Ann N Y Acad Sci; 1996 Feb; 778():288-96. PubMed ID: 8610982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse CD1 is mainly expressed on hemopoietic-derived cells.
    Brossay L; Jullien D; Cardell S; Sydora BC; Burdin N; Modlin RL; Kronenberg M
    J Immunol; 1997 Aug; 159(3):1216-24. PubMed ID: 9233616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets.
    Brossay L; Tangri S; Bix M; Cardell S; Locksley R; Kronenberg M
    J Immunol; 1998 Apr; 160(8):3681-8. PubMed ID: 9558068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.
    Tangri S; Brossay L; Burdin N; Lee DJ; Corr M; Kronenberg M
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14314-9. PubMed ID: 9826697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for antigen presentation by mouse CD1.
    Burdin N; Brossay L; Degano M; Iijima H; Gui M; Wilson IA; Kronenberg M
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10156-61. PubMed ID: 10963678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
    Brossay L; Naidenko O; Burdin N; Matsuda J; Sakai T; Kronenberg M
    J Immunol; 1998 Nov; 161(10):5124-8. PubMed ID: 9820479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclassical behavior of the mouse CD1 class I-like molecule.
    Teitell M; Holcombe HR; Brossay L; Hagenbaugh A; Jackson MJ; Pond L; Balk SP; Terhorst C; Peterson PA; Kronenberg M
    J Immunol; 1997 Mar; 158(5):2143-9. PubMed ID: 9036959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide binding and presentation by mouse CD1.
    Castaño AR; Tangri S; Miller JE; Holcombe HR; Jackson MR; Huse WD; Kronenberg M; Peterson PA
    Science; 1995 Jul; 269(5221):223-6. PubMed ID: 7542403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
    Gumperz JE
    Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Third Way: Progress on pathways of antigen processing and presentation by CD1.
    Lawton AP; Kronenberg M
    Immunol Cell Biol; 2004 Jun; 82(3):295-306. PubMed ID: 15186261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids hide or step aside for CD1-autoreactive T cell receptors.
    Cotton RN; Shahine A; Rossjohn J; Moody DB
    Curr Opin Immunol; 2018 Jun; 52():93-99. PubMed ID: 29738961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo.
    Lee DJ; Abeyratne A; Carson DA; Corr M
    J Exp Med; 1998 Feb; 187(3):433-8. PubMed ID: 9449723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
    van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
    Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The versatility of the CD1 lipid antigen presentation pathway.
    Chancellor A; Gadola SD; Mansour S
    Immunology; 2018 Jun; 154(2):196-203. PubMed ID: 29460282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1--a new paradigm for antigen presentation and T cell activation.
    Sugita M; Moody DB; Jackman RM; Grant EP; Rosat JP; Behar SM; Peters PJ; Porcelli SA; Brenner MB
    Clin Immunol Immunopathol; 1998 Apr; 87(1):8-14. PubMed ID: 9576005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.
    Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR
    Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the function of CD1-restricted T cells.
    Vincent MS; Gumperz JE; Brenner MB
    Nat Immunol; 2003 Jun; 4(6):517-23. PubMed ID: 12774075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.